Pratik Shah, Ph.D.

Pratik Shah, Ph.D.

Chair of the BoardatDesign Therapeutics· In proxies 2022–2025

Pay in FY2025+349% from the year before · Design Therapeutics stock +52.0% the same year

Pratik Shah, Ph.D. was paid $3.5M in FY2025 (Dec), up 349%. Design Therapeutics stock rose 52.0% that year.

Pay$100 in the stock at the end of FY21 → $170
Pay is from the Summary Compensation Table of each Design Therapeutics proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. ARS PharmaceuticalsPublic company · 3 yr
    • Chair of the Board2023 – Present · 3 yrNo stock prices for these years
  2. Design TherapeuticsPublic company · 4 yr
    • President, Chief Executive Officer and Chairperson2022 – Present · 4 yrStock in role -39%
  3. Annual MeetingPublic company
    • Director? – PresentNo stock prices for these years
  4. Synthorx, Inc.Public company · 8 yr
    • Director2018 – Present · 8 yrNo stock prices for these years

Roles come from the proxy statements of each company.

Boards1

  • ARS PharmaceuticalsChair · 9 yr on the boardNot independent—Paid as an executive

Board seats come from each company's latest proxy statement.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?